Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLA2G15 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | GMPR2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0006 |
mRNA | SLC9A2 | gCSI | pan-cancer | AAC | -0.24 | 0.0006 |
mRNA | GCHFR | gCSI | pan-cancer | AAC | -0.21 | 0.0006 |
mRNA | C14orf166 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0006 |
mRNA | TMEM67 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
mRNA | CASP10 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ARL17B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | VCL | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0007 |